Cover Image
Market Research Report

Hutchison MediPharma Ltd - Product Pipeline Review - 2016

Published by Global Markets Direct Product code 255990
Published Content info 49 Pages
Delivery time: 1-2 business days
Price
Back to Top
Hutchison MediPharma Ltd - Product Pipeline Review - 2016
Published: December 30, 2016 Content info: 49 Pages
Description

Summary:

Global Markets Direct's, 'Hutchison MediPharma Ltd - Product Pipeline Review - 2016', provides an overview of the Hutchison MediPharma Ltd's pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Hutchison MediPharma Ltd, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope:

  • The report provides a snapshot of the pipeline therapeutic landscape of Hutchison MediPharma Ltd
  • The report provides overview of Hutchison MediPharma Ltd including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Hutchison MediPharma Ltd's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Hutchison MediPharma Ltd's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy:

  • Evaluate Hutchison MediPharma Ltd's strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Hutchison MediPharma Ltd
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Hutchison MediPharma Ltd's pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Table of Contents
Product Code: GMDHC08187CDB

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Global Markets Direct Report Coverage
  • Hutchison MediPharma Ltd Snapshot
    • Hutchison MediPharma Ltd Overview
    • Key Facts
  • Hutchison MediPharma Ltd - Research and Development Overview
    • Key Therapeutic Areas
  • Hutchison MediPharma Ltd - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Hutchison MediPharma Ltd - Pipeline Products Glance
    • Hutchison MediPharma Ltd - Late Stage Pipeline Products
      • Phase III Products/Combination Treatment Modalities
    • Hutchison MediPharma Ltd - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Hutchison MediPharma Ltd - Early Stage Pipeline Products
      • IND/CTA Filed Products/Combination Treatment Modalities
      • Preclinical Products/Combination Treatment Modalities
  • Hutchison MediPharma Ltd - Drug Profiles
    • HMPL-012 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • HMPL-013 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • HMPL-309 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • HMPL-453 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • HMPL-507 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • HMPL-518 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • HMPL-523 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • HMPL-689 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • HMPL-813 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • savolitinib - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
  • Hutchison MediPharma Ltd - Pipeline Analysis
    • Hutchison MediPharma Ltd - Pipeline Products by Target
    • Hutchison MediPharma Ltd - Pipeline Products by Route of Administration
    • Hutchison MediPharma Ltd - Pipeline Products by Molecule Type
    • Hutchison MediPharma Ltd - Pipeline Products by Mechanism of Action
  • Hutchison MediPharma Ltd - Dormant Projects
  • Hutchison MediPharma Ltd - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Hutchison MediPharma Ltd, Key Facts
  • Hutchison MediPharma Ltd - Pipeline by Indication, 2016
  • Hutchison MediPharma Ltd - Pipeline by Stage of Development, 2016
  • Hutchison MediPharma Ltd - Monotherapy Products in Pipeline, 2016
  • Hutchison MediPharma Ltd - Phase III, 2016
  • Hutchison MediPharma Ltd - Phase II, 2016
  • Hutchison MediPharma Ltd - Phase I, 2016
  • Hutchison MediPharma Ltd - IND/CTA Filed, 2016
  • Hutchison MediPharma Ltd - Preclinical, 2016
  • Hutchison MediPharma Ltd - Pipeline by Target, 2016
  • Hutchison MediPharma Ltd - Pipeline by Route of Administration, 2016
  • Hutchison MediPharma Ltd - Pipeline by Molecule Type, 2016
  • Hutchison MediPharma Ltd - Pipeline Products by Mechanism of Action, 2016
  • Hutchison MediPharma Ltd - Dormant Developmental Projects,2016
  • Hutchison MediPharma Ltd, Other Locations

List of Figures

  • Hutchison MediPharma Ltd - Pipeline by Top 10 Indication, 2016
  • Hutchison MediPharma Ltd - Pipeline by Stage of Development, 2016
  • Hutchison MediPharma Ltd - Monotherapy Products in Pipeline, 2016
  • Hutchison MediPharma Ltd - Pipeline by Top 10 Target, 2016
  • Hutchison MediPharma Ltd - Pipeline by Route of Administration, 2016
  • Hutchison MediPharma Ltd - Pipeline by Molecule Type, 2016
  • Hutchison MediPharma Ltd - Pipeline Products by Top 10 Mechanism of Action, 2016
Back to Top